Results per Page:
Laying the groundwork for a new cancer-preventive vaccine
Fred Hutch scientists garner large NCI award to uncover secrets of immune response to virus behind Kaposi sarcoma
Immune cells vs. metastasis: ‘It’s a numbers game’
Fred Hutch scientists prevent metastasis by boosting cancer-killing T cells in patients
Early clinical trial highlights cancer vaccines as potential affordable, safe and effective breast cancer treatment
From the Cancer Vaccine Institute, University of Washington, and the Cancer Consortium Breast & Ovary Cancers Program
Un ensayo clínico inicial destaca las vacunas contra el cáncer como posible tratamiento asequible, seguro y eficaz contra el cáncer de mama
Del Cancer Vaccine Institute [Instituto de Vacunas contra el Cáncer], la Universidad de Washington y del Cancer Consortium Breast & Ovary Cancers Program [Programa de Cáncer de Mama y Ovario del Consorcio del Cáncer].
When life science gives you lemons: T cells as a vaccine platform
From the Riddell Lab, Clinical Research Division
Improving cancer vaccines with T-cell programming nanoparticles
Dr. Matthias Stephan receives grant to develop cancer vaccine–optimizing, TCR-programming nanotechnology
Galloway and Hartwell to enter Washington Life Science Hall of Fame
Awards recognize power of basic research, leadership in driving advances for patients
The latest in gynecological cancer research from the Pacific Northwest
Inaugural Northwest Gynecological Cancer Symposium brings together scientists studying ovarian, cervical and endometrial cancers
Teacher, mom — and living immunotherapy proof of principle
Three years ago she was out of options to treat her advanced cancer. Then, she enrolled in an immunotherapy clinical trial.
Good News: Malik and Bloom win ASM awards; pilot project funded by Bezos family aims to create personalized anticancer vaccines
Celebrating faculty and staff achievements
1 in 10 women is not being screened for cervical cancer
As with the HPV vaccine, a key barrier is 'missed opportunities' among doctors
The HPV cancer vaccine: Are two doses as good as three?
A reduced dosing regimen may increase vaccination adherence, decrease costs